Platelet aggregation, eicosanoid production and thrombogenic ratio in individuals at high cardiovascular risk consuming meat enriched in walnut paste. A crossover, placebo-controlled study

British Journal of Nutrition

Volumn 102, Issue 1, 2009, Pages 134-141

  Canales, Amaia ^a   Bastida, Sara ^a   Librelottto, Josana ^a   Nus, Meritxell ^a   Sánchez Muniz, Francisco J ^a   Benedi, Juana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Functional food; Low fat meat; Meat enriched in walnut paste; Platelet aggregation; Prostacyclin; Thrombogenic ratio; Thromboxane

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CHOLESTEROL; ICOSANOID; POLYUNSATURATED FATTY ACID; THROMBOXANE A2; BIOLOGICAL MARKER; THROMBOXANE B2;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MEAT; NORMAL HUMAN; OBESITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VOLUNTEER; WALNUT; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; DIET; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYTOTHERAPY; RISK; SMOKING;

JUGLANS;

6-KETOPROSTAGLANDIN F1 ALPHA; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-OVER STUDIES; DIET; FEMALE; HUMANS; JUGLANS; MALE; MEAT; MIDDLE AGED; OBESITY; PHYTOTHERAPY; PLATELET AGGREGATION; RISK; SMOKING; THROMBOXANE A2; THROMBOXANE B2;

EID: 69249208781     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450813361X     Document Type: Article

References (46)

1. Knapp HR (1997) Dietary fatty acids in human thrombosis and haemostasis. Am J Clin Nutr 65, 1687S-1698S.
2. Kwon JS, Snook JT, Wardlow GM, et al. (1991) Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. Am J Clin Nutr 54, 341-348.
3. Thijssen MA, HornstraG&Mensink RP (2005) Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J Nutr 135, 2805-2811.
4. Sinclair HM (1956) Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 270, 381-383.
5. Lee J & Hwang DH (2007) Dietary fatty acids and eicosanoids. In Fatty Acids in Foods and Their Implications, 3rd ed., pp. 715-726. Boca Raton, FL: CRC Press.
6. Hornstra G (1989) Effect of dietary lipids on platelet function and thrombosis. Ann Med 21, 53-57. (Pubitemid 19121852)
7. Hornstra G (1989) Dietary lipids, platelet function and arterial thrombosis. Wien Klin Wochenschr 101, 272-277. (Pubitemid 19098696)
8. Harris WS, Miller M, Tighe AP, et al. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12-24.
9. Chan JK, McDonald BE, Gerrard JM, et al. (1993) Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 28, 811-817.
10. Sánchez-Muniz FJ, Oubiña P, Benedí J, et al. (1998) Preliminary study platelet aggregation in postmenopausal women consuming extra virgin olive oil and high oleic acid sunflower oil. J Am Oil Chem Soc 75, 217-223.
11. Oubiña P, Sanchez-Muniz FJ, Ródenas S, et al. (2001) Eicosanoid production, thrombogenic ratio, and serum and LDL-peroxides in normo and hypercholesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components. Br J Nutr 85, 41-47.
12. Sánchez-Muniz FJ, Oubiña P, Ródenas S, et al. (2003) Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein. Eur J Nutr 42, 299-306.
13. Miller GJ (1993) Hyperlipidaemia and hypercoagulability. Prog Lipid Res 32, 61-69.
14. Gebauer SK, Psota TL & Harris WS (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, 6 Suppl., 1526S-1535S.
15. Nus M, Ruperto M & Sánchez-Muniz FJ (2004) Nuts, cardio and cerebrovascular risks. A Spanish perspective. Arch Latinoam Nutr 54, 137-148.
16. Tapsell LC, Gillen LJ, Patch CS, et al. (2004) Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27, 2777-2783.
17. Anderson KJ, Teuber SS, Gobeille A, et al. (2001) Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 13, 2837-2842.
18. Almario RU, Vonghavaravat V, Wong R, et al. (2001) Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 74, 72-79.
19. Iwamoto M, Imaizumi K, Sato M, et al. (2002) Serum lipid profiles in Japanese women and men during consumption of walnuts. Eur J Clin Nutr 56, 629-637.
20. Feldman EB (2002) The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 132, S1062-S1101.
21. Ros E, Nunez I, Pérez-Heras A, et al. (2004) A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109, 1609-1614.
22. Sabate J (1999) Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 70, 500S-503S.
23. US Food and Drug Administration Office of Nutritional Products, Labelling and Dietary Supplements (2004) Qualified Health Claims: Letter of Enforcement Discretion - Walnuts and Coronary Heart Disease. http://www.cfsan.fda.gov/,dms/ qhcnuts3.html (accessed 28 October 2004).
24. National Heart, Lung and Blood Institute (2004) ATP 3 Cholesterol Guidelines. http://www.nhlbi.nih.gov/guidelines/cholesterol (accessed 28 October 2005).
25. Aranceta Bartrina J, Pérez Rodrigo C, Ruiz Vadillo V, et al. (2005) Consumo de frutos secos en España y en Europa. In Frutos secos, salud y culturas Mediterráneas, pp. 77-96 [J Salas-Salvadó, E Ros Róala and J Sabaté Casellas, editors]. Barcelona: Glosa.
26. Serrano A, Cofrades S, Ruiz-Capillas C, et al. (2005) Nutritional profile of restructured beef steak with added walnuts. Meat Sci 70, 647-654.
27. Canales A, Benedí J, Nus M, et al. (2007) Effect of walnutenriched restructured meat in the antioxidant status of overweight/ obese senior subjects with at least one extra CHD-risk factor. J Am Coll Nutr 26, 225-232.
28. Nus M, Frances F, Librelotto J, et al. (2007) Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat. J Nutr 137, 1783-1788.
29. Olmedilla-Alonso B, Granado-Lorencio F, Herrero-Barbudo C, et al. (2008) Comsumption of restructured meat products with added walnuts has a cholesterol-lowering effect in subjects at high cardiovascular risk: a randomised, crossover, placebo-controlled study. J Am Coll Nutr 27, 342-348.
30. Basili S, Pacini G, Guagnano MT, et al. (2006) Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 48, 2531-2538.
31. Coban E, Yilmaz A & Sari R (2007) The effect of weight loss on the mean platelet volume in obese patients. Platelets 18, 212-216.
32. Vignini A, Nanetti L, Moroni C, et al. (2008) Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia. Nutr Metab Cardiovasc Dis 18, 553-558.
33. Moreiras O, Carbajal A & Cabrera L (editors) (2007) Tablas de Composición de Alimentos. Madrid: Editorial Pirámide.
34. Olmedilla Alonso B, Granado Lorencio F, Herrero Barbudo C, et al. (2005) Productos cárnicos funcionales preparados con nuez. Evaluación del efecto funcional. Alimentación 24, 37-41.
35. Cardinal DC & Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3, 135-158.
36. Hishinuma T, Yu GS, Takabatake M, et al. (1996) Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. Prostaglandins Leukot Essent Fatty Acids 54, 445-449. (Pubitemid 26313464)
37. Mensink RP, van Houwelingen AC, Kromhout D, et al. (1999) A vitamin E concentrate rich in tocotrienols had not effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 69, 213-219.
38. Bagchi D, Garg A, Krohn RL, et al. (1997) Oxygen free radical scavenging abilities of vitamin C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95, 179-189.
39. Bravo L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317-333.
40. Bagchi D, Garg A, Krohn RL, et al. (1998) Protective effect of grape proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30, 771-776.
41. MurrayM&Pizzorno J (1999) Procyanidolic oligomeriers. In The Textbook of Natural Medicine, 2nd ed., pp. 899-902 [M Murray and J Pizzorno, editors]. London: Churchill Livington.
42. Robert L, Godeau G, Gavignet-Jeannin C, et al. (1990) The effect of procyanidolic oligomers on vascular permeability. A study using quantitative morphology. Pathol Biol (Paris) 38, 608-616.
43. Anfossi G, Russo I, Massucco P, et al. (2004) Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity. Eur J Clin Invest 34, 482-489.
44. Srivastava KC (1985) Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets. Prostaglandins Leukot Med 7, 319-327.
45. Szczeklik A, Gryglewski RJ, Domagala B, et al. (1985) Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 54, 425-430.
46. Fine AM (2000) Oligomeric proanthocyanidin complexes: History, structure, and phytopharmaceutical applications. Alternative Med Rev 5, 144-151.